REG - CML Microsystems PLC - Block listing Interim Return

CML MicrosystemsAnnouncement

21/03/2019 12:45

RNS Number : 6174T
CML Microsystems PLC
21 March 2019
 


BLOCK LISTING INTERIM RETURN
 
Date: 21 March 2019
 



Name of applicant:


CML Microsystems Plc




Name of scheme:


CML Share Option Scheme




Period of return:


From:


29 November  2018


To:


21 March 2019




Balance of unallotted securities under scheme(s) from previous return:


638,538 ordinary shares of 5p each




Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):


-




Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):


(1,467) ordinary shares of 5p each




Equals:  Balance under scheme(s) not yet issued/allotted at end of period:


637,071 ordinary shares of 5p each










 



Name of contact:


Neil Pritchard, Group Financial Director




Telephone number of contact:


01621 875500



 
 
Total Voting Rights
 
In conformity with the Financial Conduct Authority's Disclosure and Transparency rules, CML Microsystems Plc hereby notifies the market that the Company's issued share capital comprises 17,075,166 ordinary shares of 5p each. All of these shares carry voting rights. In addition to these 17,075,166 ordinary shares, the total number of treasury shares held is 100,000 which do not carry voting rights. 
 
The above figure of 17,075,166 ordinary shares in the Company carrying voting rights may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FSA's Disclosure and Transparency Rules.
 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BLRPGURWWUPBGPG